Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 4 2Phase 2 2Phase 1/2 1

Status

Unknown 5Completed 5Recruiting 4Terminated 2Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 1Other hematologic neoplasm 1Dermatologic 1CNS 1

Conditions

Neoplasms 2Recurrence 1Melanoma 1Hemorrhage 1Hematologic Neoplasms 1Brain Neoplasms 1

Interventions

Carboplatin 98Cisplatin 95pembrolizumab 91Gemcitabine 81Paclitaxel 79Docetaxel 70Capecitabine 64Oxaliplatin 53Fluorouracil 51Specimen Handling 50Magnetic Resonance Spectroscopy 49Bevacizumab 49Radiotherapy 48Dexamethasone 45Cyclophosphamide 45Drug Therapy 39Leucovorin 38Doxorubicin 37Pemetrexed 35Irinotecan 34Injections 30Rituximab 29Vincristine 28Trastuzumab 26Radiosurgery 26Prednisone 26Lenalidomide 25Etoposide 25130-nm albumin-bound paclitaxel 25Radiation 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × Tranexamic Acid × Clear all
NCT06229483 2026-03-19

The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies

Nova Scotia Health Authority

Phase 3 Recruiting
102 enrolled
CNS

Brain Neoplasms, Hemorrhage

NCT05053867 2026-01-14

A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Recruiting
60 enrolled
Tumor-Agnostic

Neoplasms

NCT04448184 2026-01-08

PATH

Ottawa Hospital Research Institute

Phase 3 Recruiting
662 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT05899465 2025-03-18

PRIME

University of Aarhus

Phase 3 Recruiting
1,204 enrolled
Dermatologic

Melanoma, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡